• Profile
Close

Explained: What causes long COVID breathing problems

IANS Mar 22, 2023

Post-COVID-19 breathing problems are caused by a condition known as lung fibrosis, when damaged lungs form scar tissue, which makes it difficult for lungs to expand and contract, according to researchers.


Researchers at Stanford University showed that the overactivity of genes that regulate inflammation and immune responses leads to lung fibrosis.

Long COVID cases can be severely debilitating and resistant to treatment, said Gerlinde Wernig, Assistant Professor of Pathology, at Stanford University.

What's worse, lung function can continue to decline, even without a new COVID-19 infection, Wernig said.

The finding published in the Proceedings of the National Academy of Sciences offers hope that one day, targeted drugs could intervene to quell the genes behind the damage.

In the study, the team started by looking at lung tissue samples from five COVID-19 patients who had symptoms of the disease -- such as shortness of breath -- for one or more months. The lungs of people who had symptoms after infection with SARS-CoV-2 looked like the lungs of people with end-stage pulmonary fibrosis.

By analysing single cells from the patient's tissue samples, the scientists also saw similarities in the pattern of RNA production -- which can hint a cell's overall function -- between samples of tissue from long COVID patients and samples from patients with pulmonary fibrosis. "We saw this same pattern across all human COVID lung samples," Wernig said.

As with other lung infections, the initial COVID-19 infection in the lungs kicked off an inflammatory process. In the case of long-COVID patients, however, the immune dysfunction keeps going long after the virus is gone -- similar to what happens in chronic pulmonary fibrosis.

To test whether lung fibrosis could be firmly connected to COVID infections, they looked at lung fibrosis in an experimental model infected with a SARS-CoV-2-like virus and found significant increases in fibrosis and immune dysfunction.

"Innate immune cells go crazy after that infection," Wernig said, referring to the part of the immune system that forms the first line of defence against pathogens.

In an experimental model engineered to represent human biology, researchers showed that, when the model contracted SARS-CoV-2, scarring in the lung tissues shot up, as did levels of immune cells interleukin-6, CD47 and pJUN. There was also a bright side to these experiments.

"When we did the same experiments but blocked CD47 and Il-6, we saw very little fibrosis," Wernig said. "This hints at possible treatments for long COVID involving drugs that carry out targeted immune blockades."

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay